Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Jul 31, 2011

Filed with the SEC on Sep 13, 2011 and accepted by EDGAR at Sep 13, 2011, 14:08 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-07-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2011-05-01 to 2011-07-31$541.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2011-05-01 to 2011-07-31−$2.2mus-gaap:OperatingIncomeLoss
Income tax3 months2011-05-01 to 2011-07-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2011-05-01 to 2011-07-31−$2.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2011-05-01 to 2011-07-31−$0.04us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2011-05-01 to 2011-07-31−$1.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2011-05-01 to 2011-07-31$95.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases3 months2011-05-01 to 2011-07-31$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2011-07-31$8.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-07-31$10.9mus-gaap:AssetsCurrent
Total assetsAt period end2011-07-31$11.8mus-gaap:Assets
Current liabilitiesAt period end2011-07-31$3.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-07-31$4.6mus-gaap:Liabilities
Shareholders' equityAt period end2011-07-31−$992.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-11-052645. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.